NPI 1720397771: Open Payments
NPI 1720397771. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$101 in 5 payments from 4 companies in 2025. Trend: 2023 $23 · 2024 $92 · 2025 $101
Food & beverage: $101
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $37 |
| Tactile Systems Technology Inc | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: Ozempic, Flexitouch Plus, CAPLYTA, REXULTI.
